Stock of the Week – XERIS Biopharm (XERS)
Our Stock of the Week is XERIS Biopharm (XERS). XERS is an old favorite that has been chugging along with 20% revenue growth and is on the verge of posting positive eps. It has several potential catalysts coming up in 2025. The first is the development of a drug using...
Stock of the Week – TeraWulf, Inc. (WULF)
Our Stock of the Week is TeraWulf, Inc. (WULF). WULF started as a bitcoin mining firm, but it has evolved into and is now offering High Powered Computing (HPC) services that are used for AI and other data-intensive activities. TeraWulf is fully funded to execute its...
Stock of the Week – Hims & Hers Health, Inc (HIMS)
Our Stock of the Week is Hims & Hers Health, Inc (HIMS). HIMS is an online platform that connects patients with licensed medical professionals for a variety of health concerns, including support for sexual health, mental health, weight loss, hair regrowth, and...
Stock of the Week – CompoSecure (CMPO)
Our Stock of the Week is CompoSecure (CMPO). CompoSecure dominates the metal credit card business. It designs and makes payment cards for 8 of the top 10 U.S. card issuers, including JPMorgan Chase (JPM) and American Express (AXP). It holds over 80% market share in...
Stock of the Week – Redwire Corporation (RDW)
Our Stock of the Week is Redwire Corporation (RDW). RDW describes itself as: "A global space infrastructure and innovation company enabling civil, commercial, and national security programs. Redwire's proven and reliable capabilities include avionics, sensors, power...
Stock of the Week – Rocket Lab USA, Inc (RKLB)
Our Stock of the Week is Rocket Lab USA, Inc (RKLB). While relatively small, the space industry is one of the fastest-growing niche markets in the world. Elon Musk’s SpaceX has gained tremendous attention as it plans a Mars mission and continues to innovate after...
Stock of the Week – Fulcrum Therapeutics (FULC)
Our Stock of the Week is Fulcrum Therapeutics (FULC). Fulcrum Therapeutics is a biopharmaceutical company that focuses on developing small molecules to treat rare diseases with unmet medical needs. The company has two main programs in clinical development. The first...
Stock of the Week – TG Therapeutics (TGTX)
TG Therapeutics (TGTX) is a commercial-stage biopharmaceutical firm that treats autoimmune diseases, cancers, and other B-cell diseases. The company has received approval from the FDA for Briumvi, which treats patients with relapsing forms of multiple sclerosis. The...
Stock of the Week – Viking Therapeutics (VKTX)
Our Stock of the Week is Viking Therapeutics (VKTX). Viking is racing to launch an obesity drug that competes against Lilly (LLY) and Novo Nordisk (NVO). Preliminary results for its VK2735 showed excellent results with substantial weight reduction and fewer side...
Stock of the Week – Lantheus Holdings, Inc. (LNTH)
Our Stock of the Week is Lantheus Holdings, Inc. (LNTH). LNTH is a radiopharmaceutical company that develops, manufactures, and sells diagnostic and therapeutic products for nuclear medicine and diagnostic imaging. Their products help healthcare professionals with...
Sponsored by
